Adoption of ipilimumab in the United States: a Medicare study.
a Department of Public Health Sciences , University of Virginia , Charlottesville , VA , USA.
Nengliang
N
Yao
b Inova Schar Cancer Institute, Melanoma and Skin Cancer Center , Fairfax , VA , USA.
Sekwon
S
Jang
D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000191:economics; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000191:economics; D004059:Diffusion of Innovation; D006801:Humans; D000074324:Ipilimumab; D006278:Medicare / Q000191:economics*; D008545:Melanoma / Q000188:drug therapy / Q000191:economics; D012878:Skin Neoplasms / Q000188:drug therapy / Q000191:economics; D014481:United States
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D000074324:Ipilimumab
Immunotherapy; Medicare; adoption; community practice; diffusion